Javier Crespo
Javier Crespo
Jefe Servicio Digestivo. Hospital Universitario Marqués de Valdecilla. Profesor Titular Digestivo
Verified email at humv.es
Cited by
Cited by
Host recognition of bacterial Muramyl dipeptide mediated through NOD2 IMPLICATIONS FOR CROHN′ S DISEASE
N Inohara, Y Ogura, A Fontalba, O Gutierrez, F Pons, J Crespo, K Fukase, ...
Journal of Biological Chemistry 278 (8), 5509-5512, 2003
Sofosbuvir and ribavirin in HCV genotypes 2 and 3.
ER Zeuzem S1, Dusheiko GM, Salupere R, Mangia A, Flisiak R, Hyland RH ...
N Engl J Med 370 (21), 1993-2001, 2014
Gene expression of tumor necrosis factor α and TNF‐receptors, p55 and p75, in nonalcoholic steatohepatitis patients
J Crespo, A Cayón, P Fernández‐Gil, M Hernández‐Guerra, M Mayorga, ...
Hepatology 34 (6), 1158-1163, 2001
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.
SA Ratziu V, Harrison S, Francque S, Bedossa P, Lehert P, Serfaty L, Romero ...
Gastroenterology, 2016
Adiponectin and its receptors in non-alcoholic steatohepatitis
S Kaser, A Moschen, A Cayon, A Kaser, J Crespo, F Pons-Romero, ...
Gut 54 (1), 117-121, 2005
Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment
JM Sánchez–Tapias, M Diago, P Escartín, J Enríquez, M Romero–Gómez, ...
Gastroenterology 131 (2), 451-460, 2006
Modeling nafld disease burden in china, france, germany, italy, japan, spain, united kingdom, and united states for the period 2016–2030
C Estes, QM Anstee, MT Arias-Loste, H Bantel, S Bellentani, J Caballeria, ...
Journal of hepatology 69 (4), 896-904, 2018
Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non …
AG Ruiz, F Casafont, J Crespo, A Cayón, M Mayorga, A Estebanez, ...
Obesity surgery 17 (10), 1374, 2007
Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial
J de la Peña, E Brullet, E Sanchez‐Hernández, M Rivero, M Vergara, ...
Hepatology 41 (3), 572-578, 2005
Prevalence and significance of hepatitis C viremia in chronic active hepatitis B.
J Crespo, JL Lozano, F De la Cruz, L Rodrigo, M Rodriguez, ...
American Journal of Gastroenterology 89 (8), 1994
Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica
M Lopez-Hoyos, C Ruiz de Alegria, R Blanco, J Crespo, M Pena, ...
Rheumatology 43 (5), 655-657, 2004
Variceal ligation compared with endoscopic sclerotherapy for variceal hemorrhage: prospective randomized trial
J de la Peña, M Rivero, E Sanchez, E Fábrega, J Crespo, F Pons-Romero
Gastrointestinal endoscopy 49 (4), 417-423, 1999
Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression
J Barr, J Caballeria, I Martínez-Arranz, A Domínguez-Díez, C Alonso, ...
Journal of proteome research 11 (4), 2521-2532, 2012
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ...
The Lancet 394 (10215), 2184-2196, 2019
Plasma leptin and TNF-α levels in chronic hepatitis C patients and their relationship to hepatic fibrosis
J Crespo, M Rivero, E Fábrega, A Cayón, JA Amado, MT García-Unzeta, ...
Digestive diseases and sciences 47 (7), 1604-1610, 2002
Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma
A Cuadrado, A Orive, C García-Suárez, A Domínguez, ...
Obesity surgery 15 (3), 442-446, 2005
Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration
M Guevara, ME Baccaro, J Ríos, M Martín‐Llahí, J Uriz, L Ruiz del Arbol, ...
Liver International 30 (8), 1137-1142, 2010
Changes in the serum levels of interleukin‐17/interleukin‐23 during acute rejection in liver transplantation
E Fábrega, M López‐Hoyos, D San Segundo, F Casafont, ...
Liver Transplantation 15 (6), 629-633, 2009
Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort
JL Calleja, J Crespo, D Rincón, B Ruiz-Antorán, I Fernandez, C Perelló, ...
Journal of hepatology 66 (6), 1138-1148, 2017
Metabolomic identification of subtypes of nonalcoholic steatohepatitis
C Alonso, D Fernández-Ramos, M Varela-Rey, I Martínez-Arranz, ...
Gastroenterology 152 (6), 1449-1461. e7, 2017
The system can't perform the operation now. Try again later.
Articles 1–20